Teva unit to inject CVC’s LBO loans soon
The non-US women's health unit of Israel’s Teva Pharmaceutical Industries is mulling the option of issuing its first term loans in euros to fund its buyout by private equity firm CVC.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: